Can you provide the last earnings date for CASI PHARMACEUTICALS INC?
CASI PHARMACEUTICALS INC (CASI) last reported earnings on 11/14/2025.
CASI PHARMACEUTICALS INC (CASI) Earnings History & Surprises
NASDAQ:CASI • KYG1933S1012
Current stock price
0.2075 USD
-0.59 (-74.06%)
At close:
0.28 USD
+0.07 (+34.94%)
After Hours:
CASI Earnings overview
Past quarterly earnings results for CASI PHARMACEUTICALS INC (CASI), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Mar 30, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$0.37
- Revenue Estimate
Last Reported
Most Recent- Release Date
- Nov 14, 2025
- Period
- Q3 / 2025
- EPS Reported
- -$0.67
- EPS Surprise
- -64.22%
- Revenue Surprise
- %
Beat Rate
Last 8 Quarters 19%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -0.67 | -0.41 | -64.22% | -21.82% | 3.075M | - | -60.54% | |
| Q2 2025 | -0.86 | -0.48 | -79.39% | -56.36% | 4.175M | 6.426M | -35.03% | 4.93% |
| Q1 2025 | -0.69 | -0.62 | -10.90% | 2.82% | 6.24M | 6.222M | 0.29% | 83.04% |
| Q4 2024 | -0.61 | - | -36.00% | 13.356M | 7.542M | 77.09% | 94.30% | |
| Q3 2024 | -0.55 | -0.63 | 13.03% | -57.14% | 7.793M | 4.651M | 67.56% | -11.82% |
| Q2 2024 | -0.55 | -0.64 | 14.41% | 28.57% | 3.979M | 4.52M | -11.97% | -59.48% |
| Q1 2024 | -0.71 | -0.05 | -1,292.16% | -57.78% | 3.409M | 12.24M | -72.15% | -59.16% |
| Q4 2023 | -0.45 | -0.24 | -83.82% | 75.81% | 6.874M | 9.6M | -28.40% | -54.95% |
| Q3 2023 | -0.35 | -0.57 | 38.73% | 7.89% | 8.838M | 10.608M | -16.69% | -13.46% |
| Q2 2023 | -0.77 | -0.51 | -50.98% | -37.50% | 9.82M | 10.292M | -4.59% | 14.55% |
| Q1 2023 | -0.45 | -0.65 | 31.07% | 25.00% | 8.347M | 9.282M | -10.07% | -7.89% |
| Q4 2022 | -1.86 | -0.38 | -392.85% | -365.00% | 15.259M | 11.009M | 38.60% | 66.62% |
| Q3 2022 | -0.38 | -0.47 | 19.59% | 45.71% | 10.213M | 10.098M | 1.14% | 25.90% |
| Q2 2022 | -0.56 | -0.65 | 14.22% | -12.00% | 8.573M | 8.033M | 6.72% | 19.70% |
| Q1 2022 | -0.60 | -0.88 | 32.13% | 45.45% | 9.062M | 9.418M | -3.78% | 57.98% |
| Q4 2021 | -0.40 | -0.58 | 30.80% | 66.67% | 9.158M | 9.248M | -0.97% | 89.92% |
| Q3 2021 | -0.70 | -0.56 | -24.78% | 50.00% | 8.112M | 7.689M | 5.50% | 91.23% |
| Q2 2021 | -0.50 | -0.74 | 32.39% | 28.57% | 7.162M | 6.14M | 16.64% | 168.14% |
| Q1 2021 | -1.10 | -0.61 | -79.74% | -22.22% | 5.736M | 5.151M | 11.36% | 68.41% |
| Q4 2020 | -1.20 | -0.71 | -68.07% | - | 4.822M | 4.538M | 6.26% | - |
| Q3 2020 | -1.40 | -0.56 | -149.55% | - | 4.242M | 3.512M | 20.79% | - |
| Q2 2020 | -0.70 | -0.82 | 14.22% | - | 2.671M | 3.825M | -30.17% | - |
| Q1 2020 | -0.90 | -1.12 | 19.79% | - | 3.406M | 803.76K | 323.76% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A
Revenue beat statistics
Revenue beat (4)
3
Average Revenue beat (4)
27.48%
Max Revenue beat (4)
77.09%
Min Revenue beat (4)
-35.03%
Analysis
CASI has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, CASI has beaten the revenue estimates by 27.5% on average.
Related analysis
CASI PHARMACEUTICALS INC / CASI Earnings FAQ
Did CASI PHARMACEUTICALS INC (CASI) beat earnings estimates last quarter?
CASI PHARMACEUTICALS INC (CASI) missed EPS estimates and missed revenue estimates in the most recent quarter.